elearning programmes Archives - Page 16 of 76 - elearning for healthcare
Menu Access our elearning programmes on the elfh Hub Hub Register / Log in >

Archive for the ‘elearning programmes’ Category

New elearning for Healthcare Support Workers now available

Posted on: November 24th, 2022 by Louise Garrahan No Comments

Health Education England elearning for healthcare (HEE elfh) has worked with NHS England’s National Quality Improvement Taskforce to develop a new elearning programme – Healthcare Support Worker Certificate – Children and Young People’s Mental Health Inpatient Settings. This is the first bespoke training package co-designed for this invaluable staff group and is a much-requested learning opportunity.

Children and young people receiving care in mental health inpatient settings often spend a lot of their time with healthcare support workers, so it is fundamental that we equip them with the skills and knowledge to provide high quality therapeutic care and interventions.

The certificate is made up of 6 modules, that in total take approximately 4 hours to complete at the individual’s own pace. The 6 modules include:

  • The world of children and young people
  • The role of a healthcare support worker
  • Engagement within the children and young people’s setting
  • Professional standards and behaviours
  • Practical application in the role
  • Technical knowledge and expertise

This learning aligns with the Children and Young People Mental Health Inpatient Competence Framework and was co-designed to improve the quality of care delivered to children and young people in mental health inpatient units across the country.

For more information and to access the resource, please visit the Healthcare Support Worker Certificate – Children and Young People’s Mental Health Inpatient Settings webpage.

SCRIPT programme launches Medicines Use in Competitive Sport

Posted on: November 24th, 2022 by Vanessa Bassnett No Comments

Prescribers working with athletes or sporting professionals who are subject to the World Anti-Doping Code can access online training to understand the principles to consider and apply when prescribing or providing advice for athletes.

Medicines Use in Competitive Sport provides information on prescribing or making recommendations to manage asthma, hayfever and glucocorticoid medicines for patients who are involved in competitive sports which are subject to the World Anti-Doping Code.

The module also covers the principles to consider and apply across other medical conditions when prescribing or providing advice for athletes. Completing the course will achieve the following learning outcomes:

  • Recognise how working with competitive athletes who may be bound by the World Anti-Doping Agency (WADA) Code may affect prescribing decisions or recommendations.
  • Explain the principle of ‘strict liability’.
  • Describe the potential need for a therapeutic use exemption (TUE) in the management of competitive athletes.
  • Identify and use resources available to support prescribing and providing advice to competitive athlete populations presenting to primary care.

The course gives an oversight of the World Anti-Doping Agency (WADA) Prohibited List and advice for prescribers on the principle of ‘Strict Liability’ which applies across sport. It also includes advice on therapeutic use exemption (TUE) and some of the substances which are permitted or prohibited

Medicines Use in Competitive Sport is part of the SCRIPT learning portfolio. This module can be accessed through our SCRIPT Primary Care Portfolio here: https://www.safeprescriber.org/primary-care/

New eating disorders elearning and webinars now available

Posted on: November 10th, 2022 by Louise Garrahan No Comments

Health Education England elearning for healthcare (HEE elfh) has worked with charity BEAT, the Royal College of Psychiatrists, HEE’s Mental Health team and NHS England to develop a new elearning session and webinar series on eating disorders.

The session is designed to ensure that healthcare staff are trained to understand, identify and respond appropriately when faced with a patient with a possible eating disorder.

A series of 5 webinars for oral health teams, dietitians and community pharmacy teams is also available.

For more information and to access the resource, please visit the Eating Disorders Training for Health and Care Staff programme page.

New financial wellbeing session now added to All Our Health

Posted on: November 9th, 2022 by Louise Garrahan No Comments

A new elearning session on financial wellbeing has now been added to the All Our Health programme.

Developed by Health Education England elearning for healthcare (HEE elfh), the Office for Health Improvement and Disparities (OHID), the Money and Pensions Service and NHS England and Improvement, the resource is aimed at all health and care professionals to enhance their support for people in poverty or those struggling with their finances. It also provides information on how learners can look after their own financial wellbeing.

The session has been developed in response to evidence that shows money and health are intertwined with 90,000 people in the UK dying in poverty every year and 1 in 4 terminally ill people of working age spending the last year of their lives in poverty.

As a result, and to help address challenges in the current economic climate, the Financial Wellbeing session aims to help colleagues:

  • understand specific activities and interventions that can improve financial wellbeing and subsequently impact on health
  • understand the important difference between providing guidance to someone about their money situation and providing advice
  • think about the resources and services available in your area that can help people understand, manage and improve their financial wellbeing

The elearning also features helpful tools and resources from organisations including the Money and Pensions Service and the Wellbeing and Health Action Movement (WHAM project).

For more information and to access the resource, please visit the Financial Wellbeing session within the All Our Health programme.

All Our Health features sessions on a wide range of public health issues including obesity, mental health and wellbeing, dementia, and alcohol. Each bitesize session helps health and care professionals prevent ill health and promote wellbeing as part of their everyday practice.

Good communication: Foundation update (November 2022)

Posted on: November 7th, 2022 by Kieron Bradshaw No Comments

Welcome to your November 2022 update from the Foundation elearning programme. This month focuses on good communication.

From breaking bad news or supporting the bereavement process, to communicating issues such as treatment risks or organ donation to patients, communication skills are key to your success as a doctor. The following sessions aim to support you to sell your diagnosis, your treatment, and most of all yourself, to your patients.

The Foundation elearning programme has been developed specifically for Foundation doctors by the Academy of Medical Royal Colleges in partnership with Health Education England elearning for healthcare (HEE elfh), and is approved by the UK Foundation Programme (UKFPO).

Sessions:

The sessions cover key areas in your curriculum on:

FPC 1: Clinical Assessment

FPC 2: Clinical Prioritisation

FPC 3: Holistic Planning

FPC 4: Communication and Care

FPC 5: Continuity of Care

FPC 6: Sharing the Vision

FPC 8: Upholding Values

FPC 11: Ethics and Law

The Foundation programme has a range of other sessions that might help you. Please log in to the programme page to view more.

You can sign on to the elearning with your login supplied by elearning for healthcare at any time during your foundation training: https://www.elfh.org.uk/programmes/foundation-programme/

HORUS and TURAS have deep links to elearning for healthcare sessions from the Foundation Curriculum and are therefore accessible to all trainees, making it quicker and easier to access the appropriate session linked to the curriculum.

An evaluation survey is also available to capture feedback on these sessions.

Long-term conditions training moves to the next level

Posted on: November 2nd, 2022 by Kieron Bradshaw No Comments

New intermediate level sessions are now available within our PRosPer Long-Term Conditions elearning programme, to support staff who care for people with a range of long-term conditions.

The 4 new sessions will help colleagues build on their knowledge of personalised care and support planning, along with prehabilitation and rehabilitation for long-term conditions.

The expansion follows on from the launch of our foundation level sessions, which gave an introduction to personalised care, prehabilitation and rehabilitation.

The programme will be helpful for any staff caring for patients with a range of long-term conditions, and has been developed by Health Education England (HEE) and HEE elearning for healthcare, using materials provided by Macmillan Cancer Support.

With the population living longer there is a rise in the proportion of people living with multiple long-term conditions. A personalised approach to care and support is vital to ensure that people’s needs are fully identified and planned for, taking their strengths and developed abilities into account.

Core elements of the training include needs-led assessment, supported self-management and behaviour change.

The training will be helpful for all colleagues who directly support, or work with teams who support people with long-term conditions.

Accessing the PRosPer Long-Term Conditions elearning programme
To find out more and access the training, please visit the PRosPer Long-Term Conditions elearning programme page.

TEL News October 2022

Posted on: November 2nd, 2022 by Louise Garrahan No Comments

This month’s edition includes details of our Becoming Simulation Faculty programme, the Preparing for your Future as a Nurse programme and an award for our IV Therapy Passport programme.

Read the full issue of October’s TEL News.

 

 

 

Read October’s TEL News >

Subscribe to TEL News >

New programme about children and young people’s mental health now available

Posted on: October 26th, 2022 by Louise Garrahan No Comments

Health Education England elearning for healthcare (HEE elfh) has worked with Health Education England, NHS England and other key partners to develop a new online training platform to help staff caring for children and young people with mental health needs, autism, or learning disability in acute settings.

Children and Young People with Mental Health Needs, Autism or Learning Disability: Online resources for staff in acute settings has been developed in response to feedback from the system. This learning will help support staff to manage increased demand for children and young people’s mental health services, especially in acute settings.

The programme is aimed at staff working in acute care hospital settings, such as the emergency department or paediatric wards, who would like to enhance their confidence and skills to care for children and young people (CYP) with these specific needs.

The aim is to improve knowledge, confidence and skills to safely care for children and young people with mental health needs, autism, or learning disability.

For more information and to access the resource, please visit the Children and Young People with Mental Health Needs, Autism or Learning Disability programme page.

Updates made to the COVID-19 vaccination elearning programme

Posted on: October 19th, 2022 by Alex Drinkall No Comments

Since the COVID-19 vaccination programme went live, the content of the different sessions which make up this programme has been updated and amended as more information about the vaccines and the vaccine programme has become available.

For those who have already completed this elearning programme, these updates are detailed below, starting with the most recent.

Users may need to verify their completion of the updated COVID-19 Vaccines training for either Moderna or Pfizer. Please note that the completion date shown on their issued certificate, must be on or after the following dates to ensure that the latest version of the learning has been completed:

The original COVID-19 Vaccine Moderna session and assessment were recently updated and re-titled Moderna COVID-19 vaccines (Spikevax Original and Spikevax Bivalent). This updated learning was made live on the HEE elfh hub on the 26 August 2022. 

The original COVID-19 Vaccine Pfizer BioNTech Comirnaty 30 micrograms dose session and assessment were recently updated and re-titled Pfizer-BioNTech COVID-19 Vaccines (Comirnaty 30 Concentrate and Comirnaty Bivalent). This updated learning was made live on the HEE elfh on the 23 September 2022. 

23 September 2022

Pfizer COVID vaccine Comirnaty 30 Concentrate and Comirnaty Bivalent

Updates to include:

  • the autumn 2022 booster programme
  • latest changes to the Green Book chapter 14a
  • information about Comirnaty bivalent vaccine and its use
  • current weblinks and nomenclature
  • emphasis on and assess understanding of product differences

9 September 2022

Core Knowledge for COVID-19 Vaccinators

Updated to include:

  • the autumn 2022 booster programme and latest changes to the Green Book chapter 14a
  • currently supplied vaccines including bivalent and withdrawal of Astra Zeneca
  • addition of information about off-label use
  • current weblinks and nomenclature
  • assessment questions and answers aligned to updated session content

2 September 2022

COVID-19 Vaccine Pfizer-BioNTech (Comirnaty 10 micrograms/dose)

Updated to include:

  • the autumn 2022 booster programme (children aged 5 – 11 in risk groups)
  • latest changes to the Green Book chapter 14a and shelf-life section in the product’s SPC
  • addition of information about off-label use
  • current weblinks and nomenclature
  • assessment answers expanded

26 August 2022

COVID-19 vaccine Moderna session and assessment revised and updated to include:

  • Autumn 2022 booster programme
  • The recently approved Spikevax Bivalent vaccine
  • Clearly identify the differences between Spikevax Original and Spikevax Bivalent, including their licensing, indications and doses

The HEE elfh session for Moderna has been updated to include training for Spikevax Bivalent. Sites are reminded that staff will need to complete the updated training. Staff who accessed or completed the training before 4pm on Friday, 26 August 2022, are advised to revisit the session to ensure that they have completed the correct assessment. This is to make sure that you are confident that you have understood the similarities and differences between the two vaccines, and to be able to practice safely when using them. Your employer may ask to see proof of this.

19 January 2022

All sessions updated to include

17 January 2022

New knowledge and assessment sessions for the Pfizer BioNTech Comirnaty 10 micrograms/dose COVID-19 vaccine added

30 December 2021

All sessions updated to include

  • revisions following republication of the Green Book COVID-19 Chapter (24/12/21 version)
  • the JCVI recommendations (22/12/21) of booster doses for:
    • all young people aged 16 to 17 years
    • children and young people aged 12 to 15 who are in a clinical risk group or who are a household contact of someone who is immunosuppressed
    • children and young people aged 12 to 17 years who are severely immunocompromised and who have had a third primary dose
  • the JCVI recommendations (22/12/21) that children aged 5 to11 years in a clinical risk group or who are a household contact of someone who is immunosuppressed should be offered COVID-19 vaccination with a lower dose of the Pfizer BioNTech vaccine

17 December 2021

All sessions updated to include

  • revisions following republication of the Green Book COVID-19 Chapter (14/12/21 version)
  • updates to pregnancy sections following recommendation from JCVI that pregnancy should added to the clinical high risk groups
  • temporary suspension of the requirement for a 15 minute observation period following administration of Pfizer-BioNTech and Moderna COVID-19 vaccines

2 December 2021

All sessions updated to include

  • revisions following republication of the Green Book COVID-19 Chapter (30/11/21 version)
  • extension of recommendation for booster doses to include all 18- to 39-year-olds
  • change to a 3 month minimum interval between primary course and booster doses
  • recommendation for booster dose from 3 months after third primary dose for those who were severely immunosuppressed at the time of their first or second primary vaccine
  • recommendation for 2nd primary dose for those aged 12 to 15 years

26 November 2021

All sessions updated to include

  • revisions following republication of the Green Book COVID-19 Chapter (15/11/21 version)
  • extension of recommendation for booster doses to include 40–49-year-olds
  • recommendations for 2nd primary dose for those aged 16 and 17 years

23 September 2021

All sessions updated to include

  • revisions following republication of the Green Book COVID-19 Chapter (16.9.21 version): notably changes to management of potential contraindications
  • recommendations for booster doses
  • recommendations for 3rd primary dose for those immunosuppressed at the time of their first or second vaccine
  • vaccination recommendations for all 12 to 17 year olds

5 August 2021

All sessions updated to include

  • revisions following republication of the Green Book COVID-19 Chapter
  • Guillain-Barré syndrome
  • vaccination recommendations for 12 to 17 year olds

Core session updated to include consent for children and young people

Pfizer BioNTech vaccine session revised to detail transition from use of this vaccine under Regulation 174 to use under Conditional Marketing Authorisation

8 July 2021

Pfizer BioNTech, AstraZeneca and Moderna vaccine sessions all updated to include

  • the latest vaccine effectiveness data
  • reference to JCVI interim advice about a booster vaccination programme
  • myocarditis and pericarditis reports following the Pfizer BioNTech and Moderna vaccines
  • capillary leak syndrome reports following AstraZeneca vaccine
  • revised advice on co-administration and giving COVID-19 vaccine when other vaccines have recently been given
  • advice about mixed vaccine schedules
  • JCVI advice about the recommended interval of 8 to 12 weeks between vaccine doses
  • more information about vaccine induced thrombosis and thrombocytopenia syndrome following AstraZeneca vaccine added and updated contraindications and precautions for this vaccine
  • some minor wording changes to all sessions following recent updates to the Green Book COVID-19 chapter and new web­­links added

11 May 2021

AstraZeneca session updated to include

  • updated advice from the JCVI that an alternative to the AstraZeneca vaccine should be offered to healthy adults aged under 40 years, not only to healthy adults under 30 years as previously recommended in April

21 April 2021

All sessions updated to include

  • new JCVI advice on COVID-19 vaccination for pregnant women

AstraZeneca session more substantially updated to include

  • new advice about very rare blood clotting and unusual bleeding condition following vaccination with AstraZeneca vaccine and the subsequent new contraindications and precautions to this vaccine, including changes to age group recommendations

Some minor wording changes to all sessions following recent updates to the Green Book COVID-19 chapter and new web­­links and images added.

8 April 2021

New knowledge and assessment sessions for the Moderna COVID-19 vaccine added

16 February 2021

Core Knowledge, Pfizer BioNTech and AstraZeneca vaccine sessions all updated to include

  • advice on managing allergic history and allergies after first dose
  • updated information and clarification of advice on vaccination in pregnancy

as stated in revised Green Book COVID-19 chapter

29 January 2021

Pfizer BioNTech vaccine session:

AstraZeneca vaccine session:

  • Change to state multidose vial should be clearly labelled with the date and time of expiry rather than from when it was first punctured

Some minor wording changes in Core Knowledge, Pfizer BioNTech and AstraZeneca sessions in response to user feedback or nationally published guidance.

20 January 2021

Core Knowledge session:

  • Section on Long COVID added,
  • Section on laboratory and pathology staff and social care staff eligibility for vaccination updated to be in line with Green Book COVID-19 chapter
  • Change to wording around immunosuppression to reflect change to Green Book COVID-19 chapter about this

Pfizer BioNTech vaccine session:

  • Waste disposal section updated in response to expert feedback
  • Addition of ordering via Foundry system by PCN designated sites in response to request to add this from Specialist Pharmacy Service (SPS)
  • Change to wording of description of appearance of Pfizer BioNTech vaccine prior to dilution following change about this in the Pfizer Reg174 HCP Information document
  • Addition of link and reference to the Pfizer BioNTech vaccine healthcare professional’s training and information materials (cvdvaccine.co.uk/)

AstraZeneca vaccine session:

  • Waste disposal section updated in response to expert feedback
  • Minor wording changes to “how does the vaccine work” in response to user feedback for clarity
  • Addition of ordering via Foundry system by PCN designated sites in response to request to add this from Specialist Pharmacy Service (SPS)
  • Addition of link and reference to the Pfizer BioNTech vaccine healthcare professional’s training and information materials (cvdvaccine.co.uk/)

8 January 2021

  • Advice about obtaining an additional dose from COVID-19 Vaccine AstraZeneca vials added to AstraZeneca session
  • More information about recommended interval between first and second dose added to both AstraZeneca and Pfizer BioNTech sessions
  • More information added to section about information to provide to recipients following vaccination in both AstraZeneca and Pfizer BioNTech sessions.

31 December 2020

  • New knowledge and assessment sessions on the AstraZeneca COVID-19 vaccine added
  • Core Knowledge and Pfizer BioNTech vaccine sessions updated to include: revised advice from JCVI on pregnancy and breastfeeding, updated statement from JCVI about scheduling of vaccine doses (between 4 and 12 weeks),
  • Pfizer BioNTech session updated to include: advice on obtaining a 6th dose from a vial, and allergy precautions as stated in updated Green Book COVID-19 chapter and updated Information for Healthcare Professionals on Pfizer BioNTech COVID-19 vaccine document

December 2020

  • Core Knowledge session updated with advice about not giving COVID-19 vaccine to pregnant or breastfeeding women after the COVID-19 mRNA Vaccine BNT162b2 (Pfizer BioNTech) was authorised for use
  • New MHRA guidance added on not giving COVID-19 mRNA Vaccine BNT162b2 to those with a history of anaphylaxis to a vaccine, medicine or food or a previous dose of the vaccine and addition of 15 minute minimum observation period following vaccination
  • Some amendments to the COVID-19 mRNA Vaccine BNT162b2 session storage and reconstitution sections following republication of updated Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine document
elfh is a NHS England programme in partnership with the NHS and professional bodies